Stevanato Group Spa (STVN)
NYSE:STVN
Want to see STVN full AI Analyst Report?
STVN Stock Chart & Stats
$15.53
-$0.46(-1.91%)
At close: 4:00 PM EST
$15.53
-$0.46(-1.91%)
Day’s Range― - ―
52-Week Range$12.89 - $28.00
Previous CloseN/A
Volume58.94K
Average Volume (3M)469.16K
Market Cap
$5.09B
Enterprise Value$4.71B
Total Cash (Recent Filing)$112.73M
Total Debt (Recent Filing)$448.52M
Price to Earnings (P/E)31.0
Beta0.84
Next Earnings
Aug 11, 2026EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend Yield0.29%
Share Statistics
EPS (TTM)0.51
Shares Outstanding49,709,717
10 Day Avg. Volume266,121
30 Day Avg. Volume469,164
Financial Highlights & Ratios
PEG Ratio2.49
Price to Book (P/B)3.15
Price to Sales (P/S)4.10
P/FCF Ratio218.04
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue3.92
Enterprise Value/Gross Profit13.51
Enterprise Value/Ebitda16.20
Forecast
1Y Price Target
$26.07Price Target Upside67.87% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.61
Revenue Forecast (FY)$1.28B
Bulls Say, Bears Say
Bulls Say
BDS Product Mix And MarginsStrong demand for high-value syringes and premium cartridges in the BDS segment is driving revenue growth and margin expansion as higher-value products gain share.
Capital Spending And Cash FlowDeclining capital spending as new facilities ramp and higher-margin products increase share should boost free cash flow and returns on capital.
Contract-backed RevenueBinding customer contracts that secure minimum volumes and pricing protections reduce revenue volatility and support more predictable top-line performance.
Bears Say
Engineering Segment UnderperformanceWeakness in the Engineering segment, including shortfalls in glass conversion and device assembly, could weigh on overall profitability until operations stabilize.
Guidance And Analyst CautionGuidance coming in slightly below expectations and a neutral analyst stance highlight execution risks and may keep investor focus on non-GLP drivers and near-term cash generation.
Oral GLP Product UncertaintySensitivity to news flow around oral GLP products raises investor uncertainty and could trigger share-price volatility if expectations change.
Stevanato Group News
STVN FAQ
What was Stevanato Group Spa’s price range in the past 12 months?
Stevanato Group Spa lowest stock price was $12.89 and its highest was $28.00 in the past 12 months.
What is Stevanato Group Spa’s market cap?
Stevanato Group Spa’s market cap is $5.09B.
When is Stevanato Group Spa’s upcoming earnings report date?
Stevanato Group Spa’s upcoming earnings report date is Aug 11, 2026 which is in 72 days.
How were Stevanato Group Spa’s earnings last quarter?
Stevanato Group Spa released its earnings results on May 07, 2026. The company reported $0.128 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.008.
Is Stevanato Group Spa overvalued?
According to Wall Street analysts Stevanato Group Spa’s price is currently Undervalued.
Does Stevanato Group Spa pay dividends?
Stevanato Group Spa pays a Annually dividend of $0.061 which represents an annual dividend yield of 0.29%. See more information on Stevanato Group Spa dividends here
What is Stevanato Group Spa’s EPS estimate?
Stevanato Group Spa’s EPS estimate is 0.15.
How many shares outstanding does Stevanato Group Spa have?
Stevanato Group Spa has 49,709,717 shares outstanding.
What happened to Stevanato Group Spa’s price movement after its last earnings report?
Stevanato Group Spa reported an EPS of $0.128 in its last earnings report, beating expectations of $0.12. Following the earnings report the stock price went down -5.105%.
Which hedge fund is a major shareholder of Stevanato Group Spa?
Currently, no hedge funds are holding shares in STVN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Stevanato Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$26.07 (67.87% Upside)
$26.07 (67.87% Upside)
Blogger Sentiment
Bullish
STVN Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 504.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 3.7%
Last 30 Days ▼ 5.7%
Last 30 Days ▼ 5.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.21%
12-Months-Change
Fundamentals
Return on Equity
9.63%
Trailing 12-Months
Asset Growth
18.58%
Trailing 12-Months
Company Description
Stevanato Group Spa
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
STVN Company Deck
STVN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted strong top-line growth, robust Biopharmaceutical & Diagnostic Solutions momentum (notably syringes, biologics and GLP1 exposure), expanding high-value solution mix, margin expansion on an adjusted basis, and clear progress on strategic capacity investments. Offsetting these positives were a sharp revenue decline in the Engineering segment, segment-level gross margin compression for BDS driven by ramp-related depreciation, FX and tariff headwinds, a higher tax rate, modest free cash flow in the quarter due to heavy growth capex, and slower order conversion cycles in Engineering. Management reiterated full-year guidance and emphasized demand-driven capacity investment and operational optimization.View all STVN earnings summariesSTVN Stock 12 Month Forecast
Average Price Target
$26.07
▲(67.87% Upside)
Technical Analysis
Ownership Overview
― Insiders
48.78% Mutual Funds
42.72% Other Institutional Investors
6.18% Public Companies and
Individual Investors